| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.4 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.4 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |